Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaorui Wu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Immunology|October 10, 2022
Prognostic characteristics and clinical response to immunotherapy targeting programmed cell death 1 for patients with advanced gastric cancer with liver metastasesHuayuan Liang, Zhiwei Li, Zhicheng Huang, et al.
Journal of Translational Medicine|September 4, 2022
Association of peripheral basophils with tumor M2 macrophage infiltration and outcomes of the anti-PD-1 inhibitor plus chemotherapy combination in advanced gastric cancerChaorui Wu, Yaopeng Qiu, Renyi Zhang, et al.
Communications Biology|August 13, 2025
UBAP2L-driven stress granule formation links oxaliplatin resistance to gastric cancerChaorui Wu, Yu Yan, Qichen Chen, et al.
Molecular Therapy Oncolytics|March 1, 2022
Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancerHao Wang, Jing Wu, Ruoyu Ling, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2023
N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1α Positive Feedback LoopQingbin Yang, Xuetao Lei, Jiayong He, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Immunology|October 10, 2022
Prognostic characteristics and clinical response to immunotherapy targeting programmed cell death 1 for patients with advanced gastric cancer with liver metastasesHuayuan Liang, Zhiwei Li, Zhicheng Huang, et al.
Journal of Translational Medicine|September 4, 2022
Association of peripheral basophils with tumor M2 macrophage infiltration and outcomes of the anti-PD-1 inhibitor plus chemotherapy combination in advanced gastric cancerChaorui Wu, Yaopeng Qiu, Renyi Zhang, et al.
Communications Biology|August 13, 2025
UBAP2L-driven stress granule formation links oxaliplatin resistance to gastric cancerChaorui Wu, Yu Yan, Qichen Chen, et al.
Molecular Therapy Oncolytics|March 1, 2022
Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancerHao Wang, Jing Wu, Ruoyu Ling, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2023
N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1α Positive Feedback LoopQingbin Yang, Xuetao Lei, Jiayong He, et al.
Pageof 2